septonex has been researched along with Infant, Newborn, Diseases in 1 studies
*Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DUNOVSKY, J | 1 |
1 other study(ies) available for septonex and Infant, Newborn, Diseases
| Article | Year |
|---|---|
[OUR EXPERIENCES WITH THE USE OF SEPTONEX IN THE CONTROL OF STAPHYLOCOCCAL INFECTIONS IN NEWBORN INFANTS].
Topics: Ammonium Compounds; Anti-Infective Agents, Local; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Quaternary Ammonium Compounds; Staphylococcal Infections | 1963 |